State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold were found in a batch of cannabis flower.
Cannabis companies in Oregon now face the possibility that their product samples may be sent to a second lab of the regulator’s choosing, so the product’s contents can be verified.
Analytical Cannabis speaks to the researchers behind a new study that found that exposure to cannabis smoke can lead to problems with endothelial function, regardless of the marijuana's cannabinoid profile.
Acute physical health adverse effects were reported by 69.9% of the study's participants.
According to the administration, the products were marketed in a way that may have led consumers to purchase the items without realizing they contained CBD.
The bill was passed by the US House of Representatives in July. It then went to the Senate, which passed it on Wednesday, November 16.
This finding could have wide-reaching implications for public health, the researchers say, as the results appear to support a growing industry campaign to de-emphasize THC in the marketplace.
Applicants must propose a study that will focus on either sustainable water and energy use, pest management and fertilizer practices, or overall ecological health.
In a class action lawsuit filed on October 28, seen by Analytical Cannabis, a plaintiff alleges that pre-rolls sold by the companies Greenfield Organix and LPF JV Corporation contain less THC than advertised.